Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
…, PA Merkel, JE Pope, JR Seibold… - … of scleroderma and …, 2017 - journals.sagepub.com
… LeRoy EC Medsger TA Jr Criteria for the classification of early systemic sclerosis. J …
Steen VD Medsger TA Jr Improvement in skin thickening in systemic sclerosis associated with …
Steen VD Medsger TA Jr Improvement in skin thickening in systemic sclerosis associated with …
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
…, MD Mayes, JM Van Laar, JR Seibold… - Arthritis & …, 2013 - Wiley Online Library
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
Connective tissue disease-associated interstitial lung diseases (CTD-ILD)—report from OMERACT CTD-ILD Working Group
…, K Brown, K Flaherty, AU Wells, JR Seibold… - The Journal of …, 2015 - jrheum.org
Objective. Interstitial lung disease (ILD) is common in connective tissue disease (CTD) and
is the leading cause of mortality. Investigators have used certain outcome measures in …
is the leading cause of mortality. Investigators have used certain outcome measures in …
[HTML][HTML] Cyclophosphamide versus placebo in scleroderma lung disease
…, C Strange, M Bolster, JR Seibold… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a double-blind, randomized, placebo-controlled trial to determine
the effects of oral cyclophosphamide on lung function and health-related symptoms in …
the effects of oral cyclophosphamide on lung function and health-related symptoms in …
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
…, E Hachulla, JR Seibold… - Annals of the …, 2010 - ard.bmj.com
Objectives To determine the causes and predictors of mortality in systemic sclerosis (SSc).
Methods Patients with SSc (n=5860) fulfilling the American College of Rheumatology criteria …
Methods Patients with SSc (n=5860) fulfilling the American College of Rheumatology criteria …
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist
…, P Carpentier, J Molitor, JR Seibold… - Arthritis & …, 2004 - Wiley Online Library
Objective Recurrent digital ulcers are a manifestation of vascular disease in patients with
systemic sclerosis (SSc; scleroderma) and lead to pain, impaired function, and tissue loss. We …
systemic sclerosis (SSc; scleroderma) and lead to pain, impaired function, and tissue loss. We …
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
…, DM Rosenberg, VV McLaughlin, JR Seibold… - Annals of the …, 2014 - ard.bmj.com
Objective Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death
in systemic sclerosis (SSc), facilitates earlier treatment. The objective of this study was to …
in systemic sclerosis (SSc), facilitates earlier treatment. The objective of this study was to …
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
…, SA Jiménez, B White, JR Seibold… - Arthritis & …, 2002 - Wiley Online Library
Objective To document disease activity and functional status in patients with scleroderma (systemic
sclerosis [SSc]) and Raynaud's phenomenon (RP) and to determine the sensitivity to …
sclerosis [SSc]) and Raynaud's phenomenon (RP) and to determine the sensitivity to …
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
… LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J … Johnson
SR, Fransen J, Khanna D, Bacon M, van den Hoogen F, Medsger TA Jr, et al. Validation of …
SR, Fransen J, Khanna D, Bacon M, van den Hoogen F, Medsger TA Jr, et al. Validation of …
High‐dose versus low‐dose D‐penicillamine in early diffuse systemic sclerosis: analysis of a two‐year, double‐blind, randomized, controlled clinical trial
…, B Andrews, M Abeles, JR Seibold - … : Official Journal of …, 1999 - Wiley Online Library
Objective To test the hypothesis that systemic sclerosis (SSc) patients taking high‐dose D‐penicillamine
(D‐Pen) would have greater softening of skin, lower frequency of renal crisis, …
(D‐Pen) would have greater softening of skin, lower frequency of renal crisis, …